120 related articles for article (PubMed ID: 1472941)
1. A method for specific amplification and PCR sequencing of individual members of multigene families: application to the study of steroid 21-hydroxylase deficiency.
Collier S; Tassabehji M; Strachan T
PCR Methods Appl; 1992 Feb; 1(3):181-6. PubMed ID: 1472941
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathology of 21-hydroxylase deficiency.
Strachan T
J Inherit Metab Dis; 1994; 17(4):430-41. PubMed ID: 7967493
[TBL] [Abstract][Full Text] [Related]
3. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.
Owerbach D; Crawford YM; Draznin MB
Mol Endocrinol; 1990 Jan; 4(1):125-31. PubMed ID: 2325662
[TBL] [Abstract][Full Text] [Related]
4. A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome.
Collier S; Tassabehji M; Sinnott P; Strachan T
Nat Genet; 1993 Mar; 3(3):260-5. PubMed ID: 8485582
[TBL] [Abstract][Full Text] [Related]
5. Defective, deleted or converted CYP21B gene and negative association with a rare restriction fragment length polymorphism allele of the factor B gene in congenital adrenal hyperplasia.
Ghanem N; Lobaccaro JM; Buresi C; Abbal M; Halaby G; Sultan C; Lefranc G
Hum Genet; 1990 Dec; 86(2):117-25. PubMed ID: 1979956
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency.
Amor M; Parker KL; Globerman H; New MI; White PC
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1600-4. PubMed ID: 3257825
[TBL] [Abstract][Full Text] [Related]
7. Identification of molecular defects causing congenital adrenal hyperplasia by cloning and differential hybridization of polymerase chain reaction-amplified 21-hydroxylase (CYP21) genes.
Helmberg A; Tabarelli M; Fuchs MA; Keller E; Dobler G; Schnegg I; Knorr D; Albert E; Kofler R
DNA Cell Biol; 1992 Jun; 11(5):359-68. PubMed ID: 1605859
[TBL] [Abstract][Full Text] [Related]
8. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.
Mornet E; Crété P; Kuttenn F; Raux-Demay MC; Boué J; White PC; Boué A
Am J Hum Genet; 1991 Jan; 48(1):79-88. PubMed ID: 1985465
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic characterization of nonclassic 21-hydroxylase deficiency.
Speiser PW; New MI; White PC
Endocr Res; 1989; 15(1-2):257-76. PubMed ID: 2788081
[TBL] [Abstract][Full Text] [Related]
10. Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B.
Donohoue PA; Jospe N; Migeon CJ; Van Dop C
Genomics; 1989 Oct; 5(3):397-406. PubMed ID: 2613228
[TBL] [Abstract][Full Text] [Related]
11. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
Helmberg A; Tusie-Luna MT; Tabarelli M; Kofler R; White PC
Mol Endocrinol; 1992 Aug; 6(8):1318-22. PubMed ID: 1406709
[TBL] [Abstract][Full Text] [Related]
12. Analysis of mutations causing steroid 21-hydroxylase deficiency.
White PC
Endocr Res; 1989; 15(1-2):239-56. PubMed ID: 2788080
[TBL] [Abstract][Full Text] [Related]
13. Exon 7 Ncol restriction site within CYP21B (steroid 21-hydroxylase) is a normal polymorphism.
Donohoue PA; Sandrini Neto R; Collins MM; Migeon CJ
Mol Endocrinol; 1990 Sep; 4(9):1354-62. PubMed ID: 1978247
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.
Speiser PW; New MI; White PC
N Engl J Med; 1988 Jul; 319(1):19-23. PubMed ID: 3260007
[TBL] [Abstract][Full Text] [Related]
15. Preliminary investigation of mutations in 21-hydroxylase gene in patients with congenital adrenal hyperplasia in Russia.
Evgrafov OV; Polyakov AV; Dzenis IG; Baharev VA
Hum Mutat; 1995; 5(2):131-6. PubMed ID: 7749411
[TBL] [Abstract][Full Text] [Related]
16. Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B47,DR7 haplotype.
Chu X; Braun-Heimer L; Rittner C; Schneider PM
Exp Clin Immunogenet; 1992; 9(2):80-5. PubMed ID: 1489553
[TBL] [Abstract][Full Text] [Related]
17. Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes.
Collier S; Sinnott PJ; Dyer PA; Price DA; Harris R; Strachan T
EMBO J; 1989 May; 8(5):1393-402. PubMed ID: 2788573
[TBL] [Abstract][Full Text] [Related]
18. Linkage between I172N mutation, a marker of 21-hydroxylase deficiency, and a single nucleotide polymorphism in Int6 of CYP21B gene: a genetic study of Sardinian family.
Concolino P; Satta MA; Santonocito C; Carrozza C; Rocchetti S; Ameglio F; Giardina E; Zuppi C; Capoluongo E
Clin Chim Acta; 2006 Feb; 364(1-2):298-302. PubMed ID: 16171792
[TBL] [Abstract][Full Text] [Related]
19. Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency.
Sinnott P; Collier S; Costigan C; Dyer PA; Harris R; Strachan T
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2107-11. PubMed ID: 2315306
[TBL] [Abstract][Full Text] [Related]
20. de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings.
Tajima T; Fujieda K; Fujii-Kuriyama Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):86-9. PubMed ID: 8325964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
